HIV drug trial shows injection twice-yearly 100% effective against infection.

The Best of 702 Weekend Breakfast - Un pódcast de 702 - Domingos

Categorías:

Resident GP & CEO of Proactive Health Solutions, Dr Fundile Nyati on what to make of news of a breakthrough HIV drug trial which is said to show biannual injection to be 100% effective against infection. Findings from this breakthrough clinical trial conducted in SA and Uganda have claimed that biannual injection of a new pre-exposure prophylaxis (PrEP) drug gives young women total protection from HIV infection.See omnystudio.com/listener for privacy information.

Visit the podcast's native language site